ABOUT CiDIG
Informing patients in a timely manner and contributing broadly to people's health and longevity through interdisciplinary research involving experts in the fields of intractable disease database, genome and immunology
- Exploring approaches to intractable diseases, cancer and infectious diseases by elucidating the hidden connections between genomic and immune information.
- Utilizing platforms for high-dimensional immunological analysis seamlessly connecting non-clinical and clinical data.
- Developing immunotherapies for cancer based on clinical and genomic information.
- Operating the National Database of Designated Intractable Diseases of Japan.
(Information Security Policy (In Japanese))
NEWS
-
[ 2025.5.1 ]
About the National Database of Designated Intractable Diseases
The operation of the National Database of Designated Intractable Diseases of Japan under a contract with the Ministry of Health, Labour and Welfare, has been transferred from Laboratory of Rare Disease Information and Resource Library to Center for Intractable Diseases and ImmunoGenomics. -
[ 2025.4.1 ]
Change from "NIBIOHN" to "NIBN"
The abbreviation for the National Institutes of Biomedical Innovation, Health and Nutrition has changed from "NIBIOHN" to "NIBN." Accordingly, the URL of this website has changed to "https://cidig.nibn.go.jp/index_e.html". -
[ 2024.9.6 ]
New project starts
Laboratory of Molecular Diagnostics and Therapeutics (Project Leader: Yusukue Mizukami) is now a member of Center for Intractable Diseases and ImmunoGenomics (CiDIG). -
[ 2024.6.1 ]
Project integration
Platform of Therapeutics for Intractable Diseases has been integrated with Laboratory of Rare Disease Information and Resource Library. The National Database of Designated Intractable Diseases of Japan will be operated by Laboratory of Rare Disease Information and Resource Library. -
[ 2024.4.1 ]
Website opens
Information of the Center for Intractable Diseases and ImmunoGenomics (CiDIG) is available from this site.
